{
 "name": "醣聯",
 "slug": "tw-4168",
 "aliases": [
  "台灣醣聯生技醫藥股份有限公司",
  "GlycoNex Inc.",
  "4168"
 ],
 "ticker": "4168",
 "industry": "生技醫療業",
 "website": "http://www.glyconex.com.tw/",
 "summary": "醣聯（4168）是上櫃的生技醫療類股公司，2001 年成立，2012 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "台灣醣聯生技醫藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "GlycoNex Inc.",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2012-12-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2001-02-01",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "張東玄",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "楊玫君",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 1125213180,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.glyconex.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 0,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-當月營收；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -100,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-去年同月增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -54.86,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：累計營業收入-前期比較增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "管線：GNX1021（醣抗原標靶ADC）",
   "value": "晚期實體腫瘤｜Phase I首位受試者已給藥｜日本、台灣",
   "unit": "",
   "as_of": "2026-08-03",
   "source": "https://glyconex.com.tw/news/2026/2026-08-03-gnx1021-first-patient-dosed",
   "note": "日本完成首位給藥；多國一期試驗規劃於日本及台灣進行。"
  },
  {
   "claim": "管線：SPD8（denosumab生物相似藥）",
   "value": "骨質疏鬆症｜Phase III已完成並解盲，規劃藥證申請｜日本",
   "unit": "",
   "as_of": "2026-06-11",
   "source": "https://glyconex.com.tw/news/2026/2026-06-11-spd8-topline",
   "note": "Prolia／Pralia為參考藥商品名，不是SPD8已核准商品名。"
  },
  {
   "claim": "管線：GNX201-ADC（pro-antibody ADC）",
   "value": "實體腫瘤｜Lead Optimization，朝IND-enabling開發｜地區未揭露",
   "unit": "",
   "as_of": "2026-03-23",
   "source": "https://glyconex.com.tw/news/2026/2026-03-23-nippon-kayaku",
   "note": "與Nippon Kayaku共同開發；來源未揭露試驗執行地區，未把合作方國籍當成授權地區。"
  },
  {
   "claim": "催化劑：SPD8",
   "value": "日本藥證預期核准｜2027-Q3（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-06-11",
   "source": "https://glyconex.com.tw/news/2026/2026-06-11-spd8-topline",
   "note": "公司預估，非PMDA承諾之審查期限；未見已核准公告。"
  },
  {
   "claim": "催化劑：SPD8",
   "value": "台灣藥證預期核准｜2027-Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-06-11",
   "source": "https://glyconex.com.tw/news/2026/2026-06-11-spd8-topline",
   "note": "公司預估，非TFDA承諾之審查期限；未見已核准公告。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4168.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}